[Issuer Free Writing Prospectus, dated December 3, 2013 (Relating to Preliminary Prospectus Filed December 2, 2013) Registration Statement No. 333-190904 Dear AMC associates, As most of you know, after almost a decade in private hands, AMC Entertainment Holdings, Inc. (the parent company for AMC Theatres) is going public. For the benefit of all associates, we are reserving a number of]
[Issuer Free Writing Prospectus, dated December 3, 2013 (Relating to Preliminary Prospectus Filed December 2, 2013) Registration Statement No. 333-190904 Dear AMC associates, As most of you know, after almost a decade in private hands, AMC Entertainment Holdings, Inc. (the parent company for AMC Theatres) is going public. For the benefit of all associates, we are reserving a number of]
[Issuer Free Writing Prospectus, dated December 3, 2013 (Relating to Preliminary Prospectus Filed December 2, 2013) Registration Statement No. 333-190904 To our AMC Stubs members, AMC Entertainment Holdings, Inc., the parent company for AMC Theatres, is going public. We are reserving a number of shares in our initial public stock offering (IPO) for you, our most loyal customers, to reserve]
[Issuer Free Writing Prospectus, dated December 3, 2013 (Relating to Preliminary Prospectus Filed December 2, 2013) Registration Statement No. 333-190904 To our AMC Stubs members, AMC Entertainment Holdings, Inc., the parent company for AMC Theatres, is going public. We are reserving a number of shares in our initial public stock offering (IPO) for you, our most loyal customers, to reserve]
[Issuer Free Writing Prospectus,ted December3, 2013 (Relating to Preliminary Prospectus Filed December2, 2013) Registration Statement No.333-190904 Dear AMCsociates, most of you know, aftermost a decade in private hands, AMC Entertainments,Inc. (the parentmpany for AMC Theatres) is going public. For the benefit oflsociates, we are reserving a number of shares in our initial public stock offering]
[Issuer Free Writing Prospectus,ted December3, 2013 (Relating to Preliminary Prospectus Filed December2, 2013) Registration Statement No.333-190904 Dear AMCsociates, most of you know, aftermost a decade in private hands, AMC Entertainments,Inc. (the parentmpany for AMC Theatres) is going public. For the benefit oflsociates, we are reserving a number of shares in our initial public stock offering]
[Issuer Free Writing Prospectus,ted December 3, 2013 (Relating to Preliminary Prospectus Filed December 2, 2013) Registration Statement No. 333-190904 To our AMC Stubs members, AMC Entertainments,Inc., the parentmpany for AMC Theatres, is going public. We are reserving a number of shares in our initial public stock offering (IPO) for you, our most loyal customers, to]
[Issuer Free Writing Prospectus,ted December 3, 2013 (Relating to Preliminary Prospectus Filed December 2, 2013) Registration Statement No. 333-190904 To our AMC Stubs members, AMC Entertainments,Inc., the parentmpany for AMC Theatres, is going public. We are reserving a number of shares in our initial public stock offering (IPO) for you, our most loyal customers, to]
[FORM S-3 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 Skystar Bio-Pharmaceutical Company Nevada 2834 33-0901534 (State or other jurisdiction (Primary Standard Industrial (I.R.S. Employer of incorporation or organization) Code Number) Identification Number) 4/F Building B Chuangye Square, No. 48 Keji Road, Gaoxin District Xi’an, Shaanxi Province, P.R. China (8629) 8819-3188 (Address, including zip code, and telephone number, Bing Mei] [SKYSTAR BIO-PHARMACEUTICAL COMPANY TO AS TRUSTEE INDENTURE DATED AS OF , 20 SENIOR DEBT SECURITIES TABLE OF CONTENTS Page ARTICLE 1 DEFINITIONS AND OTHER PROVISIONS OF GENERAL APPLICATION 1 SECTION 1.1 DEFINITIONS 1 SECTION 1.2 COMPLIANCE CERTIFICATES AND OPINIONS 8 SECTION 1.3 FORM OF DOCUMENTS DELIVERED TO TRUSTEE 8] [SKYSTAR BIO-PHARMACEUTICAL COMPANY TO AS TRUSTEE INDENTURE DATED AS OF , 20 SUBORDINATED DEBT SECURITIES TABLE OF CONTENTS Page ARTICLE 1 DEFINITIONS AND OTHER PROVISIONS OF GENERAL APPLICATION 1 SECTION 1.1 DEFINITIONS 1 SECTION 1.2 COMPLIANCE CERTIFICATES AND OPINIONS 9 SECTION 1.3 FORM OF DOCUMENTS DELIVERED TO TRUSTEE 10] [CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM We hereby consent to the incorporation by reference in the Registration Statement on Form S-3 and related Prospectus of our report dated April 1, 2013 relating to the consolidated financial statements, which appears in Skystar Bio-Pharmaceutical Company’s Annual Report on Form 10-K for the year ended December 31, 2012. We also consent to] [Consent of Independent Registered Public Accounting Firm We consent to the incorporation by reference in this Registration Statement on Form S-3 and related Prospectus of Skystar Bio-Pharmaceutical Company of our report dated March 30, 2012 relating to the December 31, 2011 consolidated financial statements appearing in the Annual Report on Form 10-K of Skystar Bio-Pharmaceutical Company for the year ended]
[FORM S-3 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 Skystar Bio-Pharmaceutical Company Nevada 2834 33-0901534 (State or other jurisdiction (Primary Standard Industrial (I.R.S. Employer of incorporation or organization) Code Number) Identification Number) 4/F Building B Chuangye Square, No. 48 Keji Road, Gaoxin District Xi’an, Shaanxi Province, P.R. China (8629) 8819-3188 (Address, including zip code, and telephone number, Bing Mei] [SKYSTAR BIO-PHARMACEUTICAL COMPANY TO AS TRUSTEE INDENTURE DATED AS OF , 20 SENIOR DEBT SECURITIES TABLE OF CONTENTS Page ARTICLE 1 DEFINITIONS AND OTHER PROVISIONS OF GENERAL APPLICATION 1 SECTION 1.1 DEFINITIONS 1 SECTION 1.2 COMPLIANCE CERTIFICATES AND OPINIONS 8 SECTION 1.3 FORM OF DOCUMENTS DELIVERED TO TRUSTEE 8] [SKYSTAR BIO-PHARMACEUTICAL COMPANY TO AS TRUSTEE INDENTURE DATED AS OF , 20 SUBORDINATED DEBT SECURITIES TABLE OF CONTENTS Page ARTICLE 1 DEFINITIONS AND OTHER PROVISIONS OF GENERAL APPLICATION 1 SECTION 1.1 DEFINITIONS 1 SECTION 1.2 COMPLIANCE CERTIFICATES AND OPINIONS 9 SECTION 1.3 FORM OF DOCUMENTS DELIVERED TO TRUSTEE 10] [CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM We hereby consent to the incorporation by reference in the Registration Statement on Form S-3 and related Prospectus of our report dated April 1, 2013 relating to the consolidated financial statements, which appears in Skystar Bio-Pharmaceutical Company’s Annual Report on Form 10-K for the year ended December 31, 2012. We also consent to] [Consent of Independent Registered Public Accounting Firm We consent to the incorporation by reference in this Registration Statement on Form S-3 and related Prospectus of Skystar Bio-Pharmaceutical Company of our report dated March 30, 2012 relating to the December 31, 2011 consolidated financial statements appearing in the Annual Report on Form 10-K of Skystar Bio-Pharmaceutical Company for the year ended]
